Medix Inc. (TYO:331A)
Japan
· Delayed Price · Currency is JPY 494.00
+15.00 (3.13%)
Mar 10, 2026, 3:30 PM JST
Medix Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Revenue | 4,163 | 4,161 | 4,179 | 4,273 | 14,392 | 11,979 | Upgrade
|
| Revenue Growth (YoY) | -0.38% | -0.43% | -2.20% | -70.31% | 20.14% | -22.41% | Upgrade
|
| Cost of Revenue | 453 | 434 | 442 | 581 | 11,102 | 9,231 | Upgrade
|
| Gross Profit | 3,710 | 3,727 | 3,737 | 3,692 | 3,290 | 2,748 | Upgrade
|
| Selling, General & Admin | 2,905 | 2,878 | 2,936 | 2,907 | - | - | Upgrade
|
| Other Operating Expenses | - | - | - | - | 2,719 | 2,577 | Upgrade
|
| Operating Expenses | 2,952 | 2,925 | 2,936 | 2,907 | 2,791 | 2,647 | Upgrade
|
| Operating Income | 758 | 802 | 801 | 785 | 498.99 | 101.23 | Upgrade
|
| Interest Expense | -5 | -2 | -3 | -4 | -4.4 | -8.62 | Upgrade
|
| Interest & Investment Income | 11 | 2 | - | 24 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -4 | 149 | 4 | 17 | -42.35 | -264.8 | Upgrade
|
| EBT Excluding Unusual Items | 761 | 951 | 802 | 822 | 452.23 | -172.19 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -9 | - | - | Upgrade
|
| Asset Writedown | - | - | -1 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | -15 | -178 | - | - | Upgrade
|
| Pretax Income | 761 | 951 | 786 | 635 | 452.23 | -172.19 | Upgrade
|
| Income Tax Expense | 244 | 148 | 297 | 234 | 317.92 | -54.58 | Upgrade
|
| Net Income to Company | - | 803 | 489 | 401 | - | - | Upgrade
|
| Net Income | 517 | 803 | 489 | 401 | 134.32 | -117.62 | Upgrade
|
| Net Income to Common | 517 | 803 | 489 | 401 | 134.32 | -117.62 | Upgrade
|
| Net Income Growth | 5.73% | 64.21% | 21.95% | 198.54% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 8 | 8 | 8 | 8 | - | - | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 8 | 8 | 8 | - | - | Upgrade
|
| Shares Change (YoY) | 8.08% | 3.63% | -0.48% | - | - | - | Upgrade
|
| EPS (Basic) | 66.46 | 106.41 | 64.82 | 52.90 | - | - | Upgrade
|
| EPS (Diluted) | 63.41 | 102.72 | 64.82 | 52.90 | - | - | Upgrade
|
| EPS Growth | -2.17% | 58.46% | 22.53% | - | - | - | Upgrade
|
| Free Cash Flow | - | 485 | - | - | - | - | Upgrade
|
| Free Cash Flow Per Share | - | 62.04 | - | - | - | - | Upgrade
|
| Gross Margin | 89.12% | 89.57% | 89.42% | 86.40% | 22.86% | 22.94% | Upgrade
|
| Operating Margin | 18.21% | 19.27% | 19.17% | 18.37% | 3.47% | 0.84% | Upgrade
|
| Profit Margin | 12.42% | 19.30% | 11.70% | 9.38% | 0.93% | -0.98% | Upgrade
|
| Free Cash Flow Margin | - | 11.66% | - | - | - | - | Upgrade
|
| EBITDA | - | 847 | - | - | 571.19 | 171.76 | Upgrade
|
| EBITDA Margin | - | 20.36% | - | - | 3.97% | 1.43% | Upgrade
|
| D&A For EBITDA | - | 45 | - | - | - | - | Upgrade
|
| EBIT | 758 | 802 | 801 | 785 | 498.99 | 101.23 | Upgrade
|
| EBIT Margin | 18.21% | 19.27% | 19.17% | 18.37% | 3.47% | 0.84% | Upgrade
|
| Effective Tax Rate | 32.06% | 15.56% | 37.79% | 36.85% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.